Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
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
utx0KVE7PA0gRyDd
Listen
